Back to search
FDAFDA · Food and drugs·Recall number D-0647-2024

Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.

Published September 4, 2024 · Recall initiated: August 8, 2024

Summary

FDA records drug Class II recall D-0647-2024, published September 4, 2024 and initiated August 8, 2024. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 266 bottles; Lot: Lot: B0223H, Exp: 5/31/2026; C3023H, Exp: 9/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications - at 18-month Stability testing

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Preferred Pharmaceuticals, Inc.
Distributor
CA and NV
Lot
Lot: B0223H, Exp: 5/31/2026; C3023H, Exp: 9/30/2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03. recalled?

Yes. FDA published recall D-0647-2024 on September 4, 2024. Reported hazard: Failed Impurities/Degradation Specifications - at 18-month Stability testing

What should I do if I have this product?

Voluntary: Firm initiated · Letter